Gene: GOLGA7
Official Full Name: golgin A7provided by HGNC
Gene Summary: Involved in Golgi to plasma membrane protein transport; peptidyl-L-cysteine S-palmitoylation; and protein stabilization. Acts upstream of or within Golgi to plasma membrane transport. Located in Golgi membrane and Golgi stack. Part of palmitoyltransferase complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22990 | GOLGA7 Knockout cell line (HeLa) | Human | GOLGA7 | 1:3~1:6 | Negative | Online Inquiry |
KO22991 | GOLGA7 Knockout cell line (HCT 116) | Human | GOLGA7 | 1:2~1:4 | Negative | Online Inquiry |
KO22992 | GOLGA7 Knockout cell line (HEK293) | Human | GOLGA7 | 1:3~1:6 | Negative | Online Inquiry |
KO22993 | GOLGA7 Knockout cell line (A549) | Human | GOLGA7 | 1:3~1:4 | Negative | Online Inquiry |
GOLGA7 Gene Knockout Cell Lines are specialized cellular models engineered to have a targeted deletion of the GOLGA7 gene, which is implicated in various biological processes, including cellular transport and Golgi apparatus function. These cell lines provide a powerful tool for studying the functional consequences of GOLGA7 loss, enabling researchers to elucidate its specific roles in cellular biology and disease mechanisms.
The primary function of these knockout cell lines is to facilitate the investigation of GOLGA7's involvement in pathways related to vesicular trafficking and protein sorting, allowing for deeper insights into cellular communication and metabolic functions. By utilizing CRISPR-Cas9 gene editing technologies, the knockout cell lines ensure precise gene disruption, leading to a more defined and reproducible loss of function phenotype. This provides a reliable model for examining the downstream effects of GOLGA7 disruption in various contexts, such as cancer biology and viral infections.
Scientifically, GOLGA7 Gene Knockout Cell Lines are invaluable in both research and clinical settings, serving as models for testing therapeutic approaches targeting Golgi-related dysfunctions. They provide critical insights that could lead to novel treatment strategies for diseases where GOLGA7 is a contributing factor, such as certain cancers or genetic disorders linked to protein misfolding.
One of the significant advantages of our GOLGA7 Gene Knockout Cell Lines is their comprehensive characterization and validation. Unlike alternative cell lines that may have uncharacterized backgrounds or minimal gene editing, our products come with detailed genomic analysis, ensuring that researchers receive a precisely defined model. This critical differentiation guarantees the reliability of experimental data and enhances reproducibility in research.
For researchers and clinicians invested in understanding Golgi apparatus functions or developing targeted therapies, GOLGA7 Gene Knockout Cell Lines offer an unparalleled resource. Our cell lines provide essential insights that can propel scientific discovery and therapeutic advancements.
At [Your Company Name], we specialize in providing high-quality biological products with meticulous attention to detail and rigorous quality control, ensuring our offerings empower the scientific community to achieve groundbreaking discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.